GSK chief science officer leaves to join US startup

GlaxoSmithKline said it had appointed Tony Wood as chief scientific officer designate after Hall Barron said he was resigning the post to run a new privately owned start-up biotech company.

.

Wood, who joined GSK from Pfizer in 2017, will take over on August 1. Barron is joining Altos Labs, a new biotech company based in San Francisco, California as chief executive and co-chair.

Altos is focused on the biology of cellular rejuvenation programming with the goal of reversing disease, GSK said.